Scholars@Duke
release_alert
Welcome to the new Scholars 3.0! Read about new features and let us know what you think.
cancel

Switching the Smoothened Inhibitor May Have Benefit in Advanced Basal Cell Carcinoma.

Publication ,  Journal Article
Khalid, B; Mukherjee, S; Ibrahimi, S; Cannon, T; Gilles, E; Moreau, A; Razaq, M
Published in: Am J Ther
2018
Published version (DOI) Link to item

Duke Scholars

Trinitia Y Cannon
Author Trinitia Y Cannon Head and Neck Surgery & Communication Sciences

Published In

Am J Ther

DOI

10.1097/MJT.0000000000000721

EISSN

1536-3686

Publication Date

2018

Volume

25

Issue

3

Start / End Page

e394 / e396

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Smoothened Receptor
  • Skin Neoplasms
  • Pyridines
  • Middle Aged
  • Male
  • Humans
  • Cardiovascular System & Hematology
  • Carcinoma, Basal Cell
  • Biphenyl Compounds
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Khalid, B., Mukherjee, S., Ibrahimi, S., Cannon, T., Gilles, E., Moreau, A., & Razaq, M. (2018). Switching the Smoothened Inhibitor May Have Benefit in Advanced Basal Cell Carcinoma. Am J Ther, 25(3), e394–e396. https://doi.org/10.1097/MJT.0000000000000721
Khalid, Bilal, Sarbajit Mukherjee, Sami Ibrahimi, Trinitia Cannon, Elizabeth Gilles, Annie Moreau, and Mohammad Razaq. “Switching the Smoothened Inhibitor May Have Benefit in Advanced Basal Cell Carcinoma.” Am J Ther 25, no. 3 (2018): e394–96. https://doi.org/10.1097/MJT.0000000000000721.
Khalid B, Mukherjee S, Ibrahimi S, Cannon T, Gilles E, Moreau A, et al. Switching the Smoothened Inhibitor May Have Benefit in Advanced Basal Cell Carcinoma. Am J Ther. 2018;25(3):e394–6.
Khalid, Bilal, et al. “Switching the Smoothened Inhibitor May Have Benefit in Advanced Basal Cell Carcinoma.” Am J Ther, vol. 25, no. 3, 2018, pp. e394–96. Pubmed, doi:10.1097/MJT.0000000000000721.
Khalid B, Mukherjee S, Ibrahimi S, Cannon T, Gilles E, Moreau A, Razaq M. Switching the Smoothened Inhibitor May Have Benefit in Advanced Basal Cell Carcinoma. Am J Ther. 2018;25(3):e394–e396.

Published In

Am J Ther

DOI

10.1097/MJT.0000000000000721

EISSN

1536-3686

Publication Date

2018

Volume

25

Issue

3

Start / End Page

e394 / e396

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Smoothened Receptor
  • Skin Neoplasms
  • Pyridines
  • Middle Aged
  • Male
  • Humans
  • Cardiovascular System & Hematology
  • Carcinoma, Basal Cell
  • Biphenyl Compounds